![Klaus Orlinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Orlinger is currently the Chief Scientific Officer at HOOKIPA Pharma, Inc. He started this position in 2022.
Dr. Orlinger has an educational background, having obtained undergraduate, graduate, and doctorate degrees from the University of Vienna.
| Bedrijven | Functie | Begin |
|---|---|---|
| HOOKIPA PHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
University of Vienna
 University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
